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Abstract
Purpose To evaluate the effect of the number of readers on
the statistical results in peripheral MRA.
Materials and methods 40 patients with peripheral arterial
occlusive disease were included as a sample dataset in this
study, randomly separated into two matched groups with n=
20 patients (group 1—gadobutrol, group 2—gadoterate
meglumine) who underwent a continuous table movement
MRA of the peripheral vessels at 3 T. Image quality (IQ) of
17 vessel segments was evaluated by 5 independent readers.
The effect of the number of readers on significance and
statistical power was statistically analyzed.
Results Image quality in group 1 (gadobutrol) ranks
significantly higher compared to group 2 (gadoterade
meglumine) with a diagnostic IQ in 97% vs. 78% (p<
0.0001). For the diagnostic/non-diagnostic IQ assessment
significance was reached with one reader 1/5 times (20%),
with two readers in 4/10 (40%), with three readers in 6/10
(60%), with four readers in 4/5 (80%), with five readers in
1/1 (100%). Power considerations showed considerable
gain when increasing the number of readers.
Conclusion Increasing the number of readers in a diagnostic
MRA-study can be used to achieve a higher power or to
decrease the number of subjects included with maintained
statistical validity.
Keywords MRA.Comparison study.Power analysis.
Vessel segments.Statistical significance
Introduction
Diagnostic studies are clinical studies, designed to evaluate
different diagnostic methods/approaches. Thus, they are
subject to Good Clinical Practice and guidelines from health
authorities. Besides, due to additionally specific guidelines
[FDA [1], CPMP [2]] the efficacy of a diagnostic approach
needs to be proven by a blinded read performed by multiple,
blinded and independent clinical experts. In the majority of
cases, statistical evaluation these days is based on two or
three reader analyses. Moreover, contrary to other clinical
studies the experimental unit in diagnostic studies, i.e., the
unit to which the diagnostic procedure is applied, and the
observational unit, i.e., the unit from which the observation
is obtained, are different. For example in studies to detect
focal liver lesions by an imaging technique, the patient
serves as experimental unit, whereas the single liver lesions
are the observational unit in this instance. Statistical methods
like generalized estimation equations and the modified
adjusted Chi²-test [3] allow for analyses taking into account
correlations between units within a patient and multiple
measurements by different readers.
Up to now, sample size and power are most often based
on the assessment of a single reader whereas the analysis is
done on two or more readers’ assessments. To optimize
study designs with respect to a minimal number of patients
required and minimal overall costs, the effect of increasing
the number of readers should be considered. In addition
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as excessively overpowered studies [4]. In our study we
focused on ordinal and binary endpoints in a parallel-group
setting comparing image quality of two gadolinium-based
contrast agents (GBCAs). Currently, contrast-enhanced
magnetic resonance angiography (CE-MRA) using conven-
tional extracellular GBCA is the most widely used
technique in all day clinical routine for visualization and
assessment of vascular disease.
The purpose of our study was therefore three-fold: First, to
demonstrate the effect of different numbers of readers on the
success of an image quality comparison of two macrocyclic
GBCAs in peripheral MRA evaluating, whether more readers
reduce the number of patients required or a fixed sample size
increases the chance of success; Second, to compare the
performance of two statistic methods (generalized estimation
equations (GEEs) and the modified adjusted Chi²-test) for
binary endpoints. Third, to compare image quality of two
different macrocyclic GBCAs for peripheral MRA using a
low dose regimen of 0.07 mmol/kg BW.
Material and methods
Patients
This monocentric, randomized, retrospective open-label
study was approved by the institutional review board and
written informed consent was obtained from all patients
included in the study. Between October 2008 to November
2009 two sets of 20 age and gender-matched patients (mean
age 72 years in gadobutrol group and 69 years in gadoterate
meglumine group, 24 men/16 women) were sampled
(Table 1) out of 172 routine patients suffering from PAOD
at Fontaine stages II–IV and referred for MRA with either
gadobutrol or gadoterate meglumine. The randomization of
the administered contrast agent was based on the day of the
treatment (randomization by treatment day). The data were
stored prospectively and retrospectively analyzed.
MR-hardware
All MRA examinations were performed on a 3.0 T 32
channel whole-body MR system (MAGNETOM Tim Trio
[102×32], Siemens AG, Healthcare Sector, Erlangen,
Germany). For signal reception, a dedicated peripheral
angiography matrix coil with 36 independent coil elements,
2 body matrix coils each with 6 independent coil elements
and 2 clusters of the inbuilt spine matrix were used to cover
the entire field of view (FoV) from the diaphragm to the
feet. All these coils can be tightly fitted to the patients to
allow for high SNR. The patients were positioned supine
and feet-first. In all patients 18 G intravenous access was
obtained in the left or right cubital vein. For the
administration of contrast agent an automated power
injector (Medrad Spectris Solaris EP, Medrad Indianola,
PA) was used.
Contrast agents
For this study two macrocyclic GBCAs were used as high
complex stability [5] owing to the kinetic stability charac-
teristic. The 1.0 molar formulated gadobutrol (Gadovist
®,
Bayer Schering Pharma AG, Berlin, Germany) is a
hydrophilic, neutral (nonionic) contrast agent. The 0.5
molar formulated gadoterate meglumine (Dotarem
®, Guer-
bet, France) represents a hydrophilic, ionic contrast agent.
The T1 relaxivity (r1) of gadobutrol vs. gadoterate
meglumine is 5.0±0.3 vs. 3.5±0.2 lmmol
−1s
−1 (in plasma,
at 3.0 T and 37°C) [6]. To allow for a sufficient comparison
between the two different GBCAs the 1 M gadobutrol was
diluted 1:1 with NaCl. This results in similar contrast agent
bolus geometry as form equivalent to the 0.5 M gadoterate
meglumine.
MR imaging
To allow for correct positioning of the MRA, 2D gradient-
echo sequences localizers in coronal and transversal
Gadobutrol (n=20) Gadoterate meglumine (n=20) p-value*
Age (years) 72±11 69±10 0.2030
Male 12 12 1.0000
Female 8 8
Weight (kg) 76±15 81±23 0.5237
Renal Function (MDRD group)
1 (>89 ml/min/1,73 m²) 4 5 0.3947
2 (>60 to ≤89 ml/min/1,73 m²) 6 9
3 (>30 to ≤60 ml/min/1,73 m²) 7 6
4 (>15 to ≤30 ml/min/1,73 m²) 0 0
5( ≤15 ml/min/1,73 m²) 3 0
Table 1 Demography and base-
line characteristics for
randomization
* p-value for difference between
treatment groups
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vessel scout and a fast-view localizer were acquired to
obtain the adjustment data required for continuous table
movement (CTM), for further details see Kramer et al. [7].
A test bolus technique at the level of the renal arteries was
used to calculate the patient’s individual circulation time.
For this purpose 1 ml was injected at 1.5 ml/s followed by a
30 ml NaCl chaser at the same injection rate. The sequence
parameters of the CTM-MRA are specified in Table 2. The
z-axis field-of-view reached from the abdominal aorta to
the distal calves. The CTM-MRA sequence was acquired
before and after the administration of the contrast agent to
allow for mask subtraction. For the CTM-MRA 0.07 mmol/
kg body weight of the respective GBCA was administered
at 1.5 ml/s followed by a 30 ml NaCl chaser. The CTM-
MRA slab was positioned to include the abdominal aorta,
the pelvic vessels as well as the entire vasculature of the
leg. Because of the coronal image orientation of the entire
FoV in z direction an angulation of the FoV is not possible.
The only parameter permitting adjustment of the spatial
resolution was slice thickness. In this study, a spatial
resolution of 1.2×1.2×1.2 mm
3 was realized. This value
reflects the limit of the current implementation of the
method that is imposed by memory constraints. During the
CTM-MRA acquisition, the coil elements required to cover
the FOV around the isocenter of the magnet are selected
automatically. To cover a readout FOV of 38 cm, 18
elements are sufficient. Before table movement is initiated
in CTM-MRA, a number of lines are acquired without
moving the table. Likewise, the data acquisition is
prolonged for a few seconds at the end of the imaging
range after the table has stopped moving [7]. Table velocity
during data acquisition is influenced by several parameters;
the most important ones are the acquired spatial resolution
and the applied parallel imaging (PI) factor. In our setting
the table velocity was 22.3 mm/s.
Image evaluation
The respective image quality of CTM-MRA was evaluated
by 5 independent imaging experts with 3–10 years of
expertise in consensus according to a 4-point Likert-like
rating scale assessing overall image quality as previously
used in other studies [8, 9]. Scores allocated were: 4 =
excellent (strong enhancement of the vessels, small side-
branches seen throughout the course of the vessel, no
venous overlay), 3 = good (strong enhancement of the
vessels, some side-branches seen, non-disturbing venous
enhancement), 2 = moderate (moderate enhancement of the
vessels or no side branches seen or moderate venous
contamination), 1 = non diagnostic (poor opacification of
the vessels or disturbing venous signal).
Image quality for CMT MRA was scored for 17 vessel
segments per patient. The pre-defined segments evaluated
are shown in Table 3. As additional endpoint, the assess-
ments were dichotomized to provide information whether
the image was diagnostic (image quality scores 3 and 4) or
non-diagnostic (image quality score 1 and 2).
Statistical analysis
Differences for baseline characteristics between groups
were evaluated by Wilcoxon rank sum tests for continuous
data and Fisher’s exact tests for categorical data. The image
quality was assessed across all five readers and all 17
segments on a binary scale (diagnostic/non diagnostic) as
overall analysis by a modified adjusted Chi²-test.
Then three segments with small differences in image
quality between the two contrast agents were chosen to
analyse the image quality for each reader separately, for all
five readers and for all combinations of 2, 3, and 4 readers
to evaluate the effect of more readers’ assessments on the
significance of the differences between the contrast agents.
These were the Right common iliac artery (AIC right),
Right deep femoral artery (AFP right), and Right posterior
tibial artery (ATP right) marked bold in Table 3.
For the ordinally scaled image quality (4 point scale),
multinomial regression analysis was used based on gener-
alized estimation equations (GEEs) taking into account
multiple observations per patients (several segments within
a patient) and repeated measurements by up to five readers
of the same observational unit. GEEs are the standard
method to analyse data with multiple measures in a single
patient as in our study. It takes into account the correlation
between observations within the same patient and therefore
provides most appropriate summary statistics. Indepen-
dence was used as working correlation matrix and a
cumulative logit function as link function. The hypotheses
were defined as follows: H0: DistributiongroupA = Distribu-
tiongroupB vs. H1: DistributiongroupA ≠ DistributiongroupB.
Table 2 Sequence parameters for CTM-MRA
CTM-MRA
Parallel Imaging GRAPPA 2
Acquisition time (s) 62
Spatial resolution (mm
3) 1.2×1.2×1.2
FoV (mm) 1280×337
TR (ms) 2.43
TE (ms) 1.02
Flip angle (°) 21
Matrix 384×312
Slices/slab 88
Bandwidth (Hz/Px) 1000
Orientation Coronal
1036 Eur Radiol (2011) 21:1034–1042The dichotomized image quality (diagnostic yes/no) was
analyzed using logistic regression analysis based on GEEs
as well as the modified adjusted Chi-square approach [3]
also taking into account the correlations between observa-
tional units within a patient and multiple assessments per
unit. Again in the GEEs independence was used as working
correlation matrix. The hypotheses were defined as follows.
H0:P groupA =P groupB vs. H1:P groupA ≠ PgroupB..
Basis for the sample size considerations was the
dichotomized endpoint in a parallel group design. The
power considerations were done for a fixed sample size
of 40 patients with 20 per group. In addition, the sample
size was calculated to reach a power of about 83%, i.e.
more than 80%. Basic assumptions for the differences
between the groups were gained from the across reader
analysis of three vessel segments by all five readers with
proportions of 96% vs. 86% of segments with diagnostic
image quality. The ratio between groups was set to 1:1.
The power considerations were done by simulation
studies of 1000 runs each, simulating studies based on
the results of the average across the five readers’
assessments for between one and four observational units
per patient. The more conservative approach (GEE or
modified adjusted Chi²-test) was used for the simulation.
Two-sided p-values<0.05 were regarded as statistically
significant. A flow chart of the analyses can be found in
Fig. 1.
Statistical calculations were done with software SAS
Version 9.2 (SAS Institute Inc., Cary, NC, USA).
Results
Image quality of two different GBCA
All contrast agent administrations were performed without
complications. No adverse events were observed.
For image quality analysis 680 judgments ([20×17]×2)
were made in total by each reader; 310 vessel segments were
assessed in group 1 (gadobutrol), 281 vessel segments were
assessed in group 2 (gadoterate meglumine). In group 1, 30
vessel segments could not be assessed whereas in group 2 59
vessel segments were not assessable. For all readers the
overall medianvalue was 4 forgadobutrolwhereas gadoterate
meglumine revealed a lower overall median value of 3
(Table 3). Figure 2 illustrates an example for image quality
achieved with gadoterate meglumine and gadobutrol, respec-
tively. With all 17 segments and five readers, the proportions
of segments with diagnostic image quality across readers was
found to be 0.97 (95% CI=(0.94; 0.99)) for gadobutrol and
0.78 (95% CI=(0.70; 0.86)) for gadoterate meglumine
leading to a difference of 0.19 (95% CI=(0.10; 0.27)). This
difference was already highly significant (p<0.0001). Also
each reader’s assessment showed a highly significant
difference when evaluated separately.
Effect of different numbers of readers
To evaluate the effect of different numbers of readers on
the significance and power, we restricted the analysis to
Table 3 Vessel segments and results (Median values across patients by reader for all vessel segments given)
No Vessel segment MRA Gadobutrol Reader MRA Gadoterate meglumine Reader
12 3 451 2 3 4 5
1 Infrarenal aorta 4 4 4 4 4 3 3 3 4 4
2 Left common iliac artery 4 4 4 4 4 3 3 3 3 3
3 Right common iliac artery 4 4 4 4 4 3 3 3 3 3.5
4 Left superficial femoral artery 4 4 4 4 4 3 3 3 2.5 3
5 Right superficial femoral artery 4 4 4 4 4 3 3 3 3 3
6 Left deep femoral artery 3 3 3 4 4 3 3 3 3 3
7 Right deep femoral artery 4 3.5 3 4 4 3 3 3 3 3
8 Left popliteal artery 4 4 4 4 4 3 3 3 3 3
9 Right popliteal artery 4 4 4 4 4 3 3 3 3 3
10 Left tibiofibular trunc 3 3 3 4 4 3 3 3 3 3
11 Right tibiofibular trunc 4 4 4 4 4 3 3 3 3 3
12 Left anterior tibial artery 3 3 3.5 4 4 3 3 3 3 3
13 Right anterior tibial artery 4 4 4 4 4 3 3 3 3 3
14 Left posterior tibial artery 3 3 3 4 4 3 3 2 3 3
15 Right posterior tibial artery 3 3 3 4 4 3 3 3 3 3
16 Left peroneal artery 3 3 3 4 4 3 3 3 3 3
17 Right peroneal artery 3 3 3 4 4 3 3 3 3 3
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contrast agents was less dominant. The statistical
significances for the ordinal (4 point scale) and dichot-
omized image quality (diagnostic yes/no) on the three
segments per patient are summarized in Tables 4 and 5.
For the ordinal endpoint, again the differences were
significant in all scenarios, even with any single reader
assessment. For the binary endpoint, with one reader
assessment, only in 1 of 5 cases (20%), significance was
reached, with two readers in 4 of 10 cases (40%), with
three readers in 6 of 10 cases (60%), with four readers in
4 of 5 cases (80%) and with all five readers. The GEE
approach for binary data was found to be slightly more
conservative compared to the adjusted modified Chi²-test
as the p-values in the GEE analysis were found to be
slightly higher in all scenarios analyzed. Therefore the
GEE approach was used for the simulation study on power
and sample size.
Power and sample size
In Figs. 3 and 4 the power and sample size considerations
are summarized for two, three, and four observational units
per patient. For a sample size of 40 and 3 units per patient,
the power starts at 29% for a single reader and increased to
79% when five readers would be included into the study,
see Fig. 4. The required sample size for a power of about
83% consequently decreased from 120 to 44 for one and
five readers, respectively (Fig. 3). Overall, the required
number of patients needed for the analysis can be reduced
by increasing the number of observational units per patient
where possible (e.g. eight liver segments instead of two
liver lobes per patient) and/or by increasing the number of
readers assessing all images. With an intra-individual
comparison design, where the contrast agents would be
applied in a paired fashion, the power is already close to
80% with one reader and 40 patients and reaches 96% with
Fig. 1 Flow chart of statistical
analyses performed
Fig. 2 A Full-thickness coronal
MIP of the CTM MRA of a
patient illustrates the image
quality of gadoterate meglumine
(a) vs gadobutrol (b). Especially
the distal calf vessels could be
depicted more clearly using
gadobutrol, which was also
reflected by the statistically
significant higher median values
for gadobutrol for all readers
1038 Eur Radiol (2011) 21:1034–10422 readers. In this example, the required sample size is also
much lower than in an inter-individual comparison study
leading to sample sizes below 20 when including more then
2 readers.
Discussion
Several publications exist on sample size considerations for
multi-reader, multi-case receiver operating characteristic
(ROC) studies and how to choose/reduce the number of
readers [10, 11]. To our knowledge, our study is the first to
demonstrate the effect of different numbers of independent
and blinded readers on the statistical significance and
power of image quality evaluation based on the comparison
of two different GBCAs for peripheral MRA. Since image
quality of the two contrast agents was so different, we
restricted the analysis to three vessel segments with minor
differences to evaluate significance and power of the study
design. Another reason was that GEEs should only be used
with cluster sizes of four or less.
Image quality evaluation is often based on the analyses
of two blinded readers. However, a higher number of
readers could reduce the sample size or, at a fixed sample
size, increase the power in a parallel-group setting, as used
in our study. When designing a specific study, costs, access
to patients and qualified readers need to be taken into
account to optimize the study design in terms of sample
size and number of readers. In this context it also needs to
be considered which of both, the number of patients
recruited, or the number of experienced readers available,
are easier to accomplish for the specific study design. The
Table 4 Proportions of patients with diagnostic image quality along with differences between contrast agents and 95% confidence intervals
(modified adjusted Chi2-test, N=2*20, 3 segments per patient)
Reader included Gadobutrol (95% CI) Gadoterate meglumine (95% CI) Difference in proportions (95% CI)
1 0.94 (0.88; 1.00) 0.83 (0.70; 0.97) 0.11 (−.04; 0.26)
2 0.96 (0.91; 1.00) 0.85 (0.73; 0.97) 0.11 (−.02; 0.24)
3 0.96 (0.91; 1.00) 0.76 (0.62; 0.90) 0.20 (0.05; 0.35)
4 0.96 (0.91; 1.00) 0.92 (0.84; 0.99) 0.04 (−.05; 0.14)
5 0.96 (0.91; 1.00) 0.92 (0.84; 0.99) 0.04 (−.05; 0.14)
1 2 0.95 (0.90; 1.00) 0.84 (0.72; 0.97) 0.11 (−.03; 0.25)
1 3 0.95 (0.90; 1.00) 0.80 (0.67; 0.93) 0.16 (0.01; 0.30)
1 4 0.95 (0.91; 0.99) 0.88 (0.80; 0.95) 0.08 (−.01; 0.16)
1 5 0.95 (0.91; 0.99) 0.88 (0.80; 0.95) 0.08 (−.01; 0.16)
2 3 0.96 (0.92; 1.00) 0.81 (0.68; 0.93) 0.16 (0.03; 0.29)
2 4 0.96 (0.93; 1.00) 0.89 (0.81; 0.96) 0.08 (−.00; 0.16)
2 5 0.96 (0.93; 1.00) 0.89 (0.81; 0.96) 0.08 (−.00; 0.16)
3 4 0.96 (0.93; 1.00) 0.84 (0.76; 0.92) 0.12 (0.04; 0.21)
3 5 0.96 (0.93; 1.00) 0.84 (0.76; 0.92) 0.12 (0.04; 0.21)
4 5 0.96 (0.91; 1.00) 0.92 (0.84; 0.99) 0.04 (−.05; 0.14)
1 2 3 0.95 (0.91; 1.00) 0.81 (0.69; 0.94) 0.14 (0.01; 0.27)
1 2 4 0.96 (0.92; 0.99) 0.87 (0.78; 0.96) 0.09 (−.01; 0.18)
1 2 5 0.96 (0.92; 0.99) 0.87 (0.78; 0.96) 0.09 (−.01; 0.18)
1 3 4 0.95 (0.92; 0.99) 0.84 (0.74; 0.93) 0.12 (0.02; 0.22)
1 3 5 0.96 (0.92; 0.99) 0.84 (0.74; 0.93) 0.12 (0.02; 0.22)
1 4 5 0.96 (0.92; 0.99) 0.89 (0.82; 0.96) 0.07 (−.01; 0.14)
2 3 4 0.96 (0.93; 0.99) 0.84 (0.76; 0.93) 0.12 (0.03; 0.21)
2 3 5 0.96 (0.93; 0.99) 0.84 (0.76; 0.93) 0.12 (0.03; 0.21)
2 4 5 0.96 (0.92; 1.00) 0.90 (0.83; 0.96) 0.07 (−.01; 0.14)
3 4 5 0.96 (0.92; 1.00) 0.87 (0.80; 0.93) 0.10 (0.02; 0.17)
1 2 3 4 0.96 (0.92; 0.99) 0.84 (0.74; 0.94) 0.12 (0.01; 0.22)
1 2 3 5 0.96 (0.92; 1.00) 0.84 (0.75; 0.94) 0.12 (0.01; 0.22)
1 2 4 5 0.96 (0.92; 0.99) 0.88 (0.81; 0.95) 0.08 (−.01; 0.16)
1 3 4 5 0.96 (0.92; 0.99) 0.86 (0.78; 0.93) 0.10 (0.02; 0.18)
2 3 4 5 0.96 (0.93; 0.99) 0.86 (0.79; 0.93) 0.10 (0.02; 0.18)
1 2 3 4 5 0.96 (0.92; 0.99) 0.86 (0.78; 0.94) 0.10 (0.01; 0.19)
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study demonstrated, that first, at a constant sample size
more readers increase the chance of a positive study
outcome and second, an increased number of readers
allows to reduce the sample size without diminishing the
power of a study. Thus, the highest gain in statistical power
could be derived by increasing the number of readers from
one to two as well as from two to three. For more than three
readers, the gain becomes less significant. The power
considerations, performed on 3 vessel segments per patient,
demonstrate intra-individual study designs, if feasible,
being advantageous over parallel-group designs.
However, there are some limitations to the statistical
approaches used. If the sample size is below n=20,
statistical methods like GEEs or the adjusted modified
Chi-square test may not be appropriate as the approxima-
tion to the Chi-square distribution is not given any more.
For cluster sizes of more than four, i.e. when more than four
observational units are observed per patient, one should
avoid GEEs and use the adjusted modified Chi-square test
or mixed effects models for data evaluation instead. The
current study was evaluated by five readers only, so that
extrapolations of these results to more than five readers are
speculative. However, the results show that already increas-
ing the number readers from 4 to 5 is less effective than
increasing the number of readers from 3 to 4. Nevertheless,
when planning a new study, the possible effect of additional
readers on the power as well as the costs of the study needs
to be considered. The questions to be answered are,
whether the gain in power, i.e. the reduced costs due to a
reduced sample size, justifies increased costs due to the
higher number of readers, and, whether it is easier to recruit
more patients or more readers. It should also be kept in
Fig. 4 Power for a sample size of 40 patients overall (2*20) for
different numbers of readers and different numbers of units per patient
in a parallel group design, “3 units paired” = intra-individual
comparison study
Fig. 3 Sample size for a power of ~83% for different numbers of
readers and different numbers of units per patient in a parallel group
design, “3 units paired” = intra-individual comparison study
Table 5 P-values of the blinded reading for the binary and ordinal
image quality comparisons of contrast agents (N=2*20, 3 segments
per patient)
Reader included GEE
Ordinal*
GEE
Binary*
Mod. adj. Chi²-test
Binary*
1 0.0017 0.1472 0.1344
2 0.0011 0.1065 0.1019
3 0.0005 0.0131 0.0129
4 <.0001 0.3523 0.3334
5 <.0001 0.3417 0.3245
12 0.0013 0.1207 0.1189
13 0.0004 0.0371 0.0301
14 <.0001 0.0896 0.0840
15 <.0001 0.0879 0.0821
23 0.0004 0.0259 0.0198
24 <.0001 0.0719 0.0666
25 <.0001 0.0704 0.0649
34 <.0001 0.0087 0.0047
35 <.0001 0.0085 0.0045
45 <.0001 0.3469 0.3548
123 0.0005 0.0469 0.0405
124 <.0001 0.0831 0.0772
125 <.0001 0.0821 0.0762
134 <.0001 0.0243 0.0176
135 <.0001 0.0239 0.0173
145 <.0001 0.1033 0.0949
234 <.0001 0.0173 0.0117
235 <.0001 0.0171 0.0115
245 <.0001 0.0952 0.0870
345 <.0001 0.0181 0.0120
1234 <.0001 0.0340 0.0270
1235 <.0001 0.0335 0.0267
1245 <.0001 0.0754 0.0683
1345 <.0001 0.0242 0.0170
2345 <.0001 0.0191 0.0127
12345 <.0001 0.0302 0.0228
*s i g n i f i c a n tp-values (< 0.05) are shown in bold font, ordinal = 4-point
scale, binary = dichotomous scale
1040 Eur Radiol (2011) 21:1034–1042mind that the effect of a greatly differing image quality
analysis by one single reader would better balanced by a
large than a low number of readers.
Peripheral MRA is an excellent, non-invasive imaging
method that routinely guides clinical decisions and has been
widely used as the first-line diagnostic tool in arterial vessel
imaging [12–14]. A number of studies have already
demonstrated the value of contrast-enhanced, high spatial
resolution MRA for the peripheral vasculature [15, 16]. The
success of peripheral MRA is thereby based on recent
technical developments like higher field strengths, multi-RF
receiver channels and dedicated receiver coils as the 36-
element coil that allows for a more effective implementa-
tion of parallel imaging[17, 18] without a significant loss in
SNR [19, 20]. The beneficial SNR gains of 3.0 T scanners
can thereby be translated in a higher temporal and/or spatial
resolution. Besides, the field strength reduces the T1-
shortening of gadolinium chelates while increasing the
T1-relaxation of the protons of the stationary background
tissue [21, 22] and thus improving the detectability of even
small vessels of the vessel periphery. In this study, we used
a dose level 0.07 mmol/kgBW for the entire run-off
vasculature Using a low dose regimen, which was
evaluated for gadobutrol before in a separate study [9],
the overall diagnostic image quality was significantly
higher for gadobutrol than for gadoterate meglumine, which
may be mainly related to the 40% higher relaxivity at 3.0 T
compared gadoterate meglumine [6]. The 1:1 dilution of the
1.0 M gadolinium chelate, gadobutrol, with saline, resulting
in a contrast agent bolus geometry similar to the 0.5 M
gadolinium chelate, gadoterate meglumine, might have
particularly disadvantaged gadobutrol compared to gado-
terate meglumine by reducing the higher T1-shortening, a
combination effect of relaxivity and concentration.
The superior image quality of gadobutrol has already
been proven in many instances [20, 23, 24]. Goyen et al.
demonstrated superior image quality of gadobutrol vs 0.5
M Gd-DTPA, both injected at the same dose level, for
whole body-MRA in healthy volunteers [23]. Mean signal-
to-noise ratio and contrast-to-noise ratio values were
significantly higher using gadobutrol. In an intraindividual
comparative study at abdominal contrast-enhanced 3D MR
angiography, depiction of small abdominal vessels was
significantly better and vessel-to-tissue contrast significant-
ly higher with 1.0 M gadobutrol than with an equimolar
dose of 0.5 M Gd-DTPA [20].
Our comparison of two different macrocyclic GBCA,
with the lowest propensity to release gadolinium [5], in
clinically evaluated low-dose protocols at 3.0 T, favors the
high T1-relaxivity [6] GBCA, gadobutrol over gadoterate
meglumine. A gadobutrol enhanced low-dose protocols at
3.0 T can be considered to be an appropriate strategy
especially in risk patients (e.g. severe renal impairment) [9].
The median image quality was thoroughly assessed as
good or excellent by all readers, except for one segment in
the gadoterate meglumine group, assessed as moderate by
two readers. In the calf station image quality of many
vessels segments were assessed as non-excellent, mainly
due to venous enhancement and delayed flow due to filling
over collateral vessels. Altered hemodynamics and venous
overlay are a common problem in diagnostic MRA, which
can be solved by time-resolved MRA, which was not part
of the current study, but could deliver purely arterial images
without venous overlay and therefore increase diagnostic
accuracy for the calf station as already proven in a previous
study [9].
One major limitation of this study is that no independent
standard of truth was available. Therefore, the sensitivity
and specificity of the gadobutrol-enhanced or the gadoterate
meglumine-enhanced MRA could not be established. The
results of the analysis of significance and power might be
influenced by our specific clinical study used for the data
generation, but mainly on the size of the effect and not the
direction.
Conclusion
This study demonstrates three major facts: First, peripheral
MRA with gadobutrol allows for a higher diagnostic
confidence than peripheral MRAwith gadoterate meglumine.
Second, based on these data it could be shown that increasing
the number of readers can be equally effective as including a
higher number of patients for the evaluation of efficacy in
diagnostic contrast agent studies. Third, the statistical
approaches GEE and modified adjusted Chi²-test lead to
similar p-values when analyzing binary endpoints.
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